Clinical Trial Update: Combination Probiotic: BB-12 With LGG (Different Doses) in Treating Children With Autism Spectrum Disorder [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes an ongoing Phase 1/Phase 2 study evaluating a combination probiotic therapy of BB-12 and Lactobacillus rhamnosus GG for chi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• BB-12 (Bifidobacterium animalis subsp. lactis BB-12)
• LGG (Lactobacillus rhamnosus GG)

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Autism Spectrum Disorder, Gastrointestinal Symptoms | Phase 1, Phase 2 | Status: RECRUITING